Tech Company Financing Transactions
Phialogics Funding Round
On 5/5/2023, Phialogics secured $672.6 thousand in Seed funding from High-Tech Gründerfonds.
Transaction Overview
Company Name
Announced On
5/5/2023
Transaction Type
Venture Equity
Amount
$672,630
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to further develop its lead candidate in preclinical models in comparison to the current standard of care and other research approaches.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Hegenheimermattweg 167A
Allschwil, 4123
CH
Allschwil, 4123
CH
Phone
Undisclosed
Website
Email Address
Overview
Dveloper of cell therapies designed for the treatment of auto-immune diseases. The company offers cell-type-specific immune checkpoint activators by using protein engineering of receptor ligands to generate signaling agonists that modulate the activity of immune cells, enabling users to prevent multi-organ failure in autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andreas Ernst
Co-Founder
Andreas Knethen
Co-Founder
Pascal Oromi
Browse more venture capital transactions:
Prev: 5/5/2023: Pimentae venture capital transaction
Next: 5/5/2023: Praktis venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs